Showing results (81-90 of 142) with videos related to
Sort By:
Pageof 15
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 22, 2020
Multicenter, retrospective analysis of endovascular treatment for acute ischemic stroke in nonagenariansHelena Janssen, Stefania Nannoni, Olivier Francois, et al.Stroke|February 28, 2013
Safety of thrombolysis in stroke mimics: results from a multicenter cohort studySanne M Zinkstok, Stefan T Engelter, Henrik Gensicke, et al.Journal of Neurology|June 13, 2015
Risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS)Barbara Goeggel Simonetti, Marie-Luise Mono, Uyen Huynh-Do, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2023
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRAS<sup>G12C</sup>-Mutant Lung CancerAli Chour, Julie Denis, Céline Mascaux, et al.Annals of Emergency Medicine|October 24, 2025
Multiple Health Care Encounters Prior to Diagnosis of Cerebral Venous ThrombosisLily W Zhou, Vanessa Dizonno, Jennifer Mandzia, et al.Neurology|October 15, 2013
IV thrombolysis and renal functionHenrik Gensicke, Sanne M Zinkstok, Yvo B Roos, et al.JCO Precision Oncology|September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting <i>ALK</i> and <i>ROS1</i> Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung CancerLaura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trialG Zalcman, A Madroszyk, E Guenzi, et al.Stroke|July 17, 2012
Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 cities young stroke studyJukka Putaala, Nilufer Yesilot, Ulrike Waje-Andreassen, et al.Stroke|September 7, 2023
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous ThrombosisThalia S Field, Vanessa Dizonno, Mohammed A Almekhlafi, et al.Pageof 15